sb 203580 has been researched along with ciglitazone in 3 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ciglitazone) | Trials (ciglitazone) | Recent Studies (post-2010) (ciglitazone) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 473 | 0 | 77 |
| Protein | Taxonomy | sb 203580 (IC50) | ciglitazone (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 4.655 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.086 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.22 | |
| Adenosine receptor A3 | Homo sapiens (human) | 3.047 | |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Homo sapiens (human) | 2.7 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.047 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.22 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.225 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.047 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Dai, J; Remick, DG; Wang, X; Zeng, X | 1 |
| Kim, YK; Kwon, CH; Yoon, CS | 1 |
3 other study(ies) available for sb 203580 and ciglitazone
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes.
Topics: Antioxidants; Cells, Cultured; Chemokine CCL2; Chromans; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Genistein; Homocysteine; Humans; Imidazoles; Indoles; Interleukin-8; Monocytes; Naphthalenes; Onium Compounds; Pyridines; Pyrrolidines; Reactive Oxygen Species; RNA, Messenger; Sulfonamides; Thiazoles; Thiazolidinediones; Thiocarbamates; Time Factors; Troglitazone; Tyrphostins | 2003 |
Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Apoptosis Inducing Factor; Blotting, Western; Cell Line; Cell Nucleus; Cell Survival; Chromans; Clofibric Acid; Dose-Response Relationship, Drug; Epithelial Cells; Fibric Acids; Flow Cytometry; Fluorescent Antibody Technique; G1 Phase; Imidazoles; Kidney Tubules; Membrane Potential, Mitochondrial; Opossums; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Pyridines; Thiazolidinediones; Troglitazone | 2008 |